SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Aug 2024 Evaluate
The sales moved up 39.82% to Rs. 2545.27 millions for the June 2024 quarter as compared to Rs. 1820.41 millions during the year-ago period.Net profit declined -27.55% to Rs. 320.15 millions from Rs. 441.91 millions.Operating profit for the quarter ended June 2024 decreased to 494.18 millions as compared to 593.81 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2545.27 1820.41 39.82 2545.27 1820.41 39.82 8532.73 6552.04 30.23
Other Income 81.52 326.23 -75.01 81.52 326.23 -75.01 620.73 604.82 2.63
PBIDT 494.18 593.81 -16.78 494.18 593.81 -16.78 2020.08 1523.85 32.56
Interest 2.83 2.62 8.02 2.83 2.62 8.02 9.88 36.13 -72.65
PBDT 491.35 591.19 -16.89 491.35 591.19 -16.89 2010.20 1487.72 35.12
Depreciation 68.36 47.24 44.71 68.36 47.24 44.71 291.28 167.37 74.03
PBT 422.99 543.95 -22.24 422.99 543.95 -22.24 1718.92 1320.35 30.19
TAX 102.84 102.04 0.78 102.84 102.04 0.78 381.34 291.69 30.73
Deferred Tax -0.74 26.94 -102.75 -0.74 26.94 -102.75 6.78 -1.71 -496.49
PAT 320.15 441.91 -27.55 320.15 441.91 -27.55 1337.58 1028.66 30.03
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 45316.00 -99.00
PBIDTM(%) 19.42 32.62 -40.48 19.42 32.62 -40.48 23.67 23.26 1.79

Marksans Pharma Share Price

199.60 -3.60 (-1.77%)
12-May-2026 14:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1859.80
Dr. Reddys Lab 1276.30
Cipla 1301.25
Zydus Lifesciences 935.45
Lupin 2265.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×